Clinical Trial Update: Mesenchymal Stem Cells for Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating mesenchymal stem cells for multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Karolinska Institutet | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED